The Clorox Company (NYSE:CLX ) Q4 2024 Earnings Conference Call August 1, 2024 5:00 PM ET Company Participants Lisah Burhan - VP, IR Linda Rendle - Chair and CEO Kevin Jacobsen - CFO Conference Call Participants Filippo Falorni - Citi Peter Grom - UBS Andrea Teixeira - JPMorgan Chris Carey - Wells Fargo Bonnie Herzog - Goldman Sachs Dara Mohsenian - Morgan Stanley Kaumil Gajrawala - Jefferies Kevin Grundy - BNP Paribas Robert Moskow - TD Cowen Olivia Tong - Raymond James Lauren Lieberman - Barclays Steve Powers - Deutsche Bank Operator Good day, ladies and gentlemen, and welcome to the Clorox Company Fourth Quarter Fiscal Year 2024 Earnings Release Conference Call. At this time, all participants are in a listen-only mode.
Although the revenue and EPS for Clorox (CLX) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Clorox (CLX) came out with quarterly earnings of $1.82 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $1.67 per share a year ago.
Bleach maker Clorox forecast annual profit above estimates after beating fourth-quarter profit on Thursday, banking on consecutive price hikes of its home care products and easing input costs that improved margins.
Clorox's (CLX) strategy of incremental dividend growth not only bolsters shareholder income but also reinforces investor confidence in the company.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Besides Wall Street's top -and-bottom-line estimates for Clorox (CLX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
Clorox's (CLX) Q4 results are expected to reflect gains from pricing strategies and cost-saving initiatives, as well as progress on the IGNITE strategy, amid high SG&A expenses.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
If you want to invest smartly, look no further than dividend stocks. These powerful investments offer the best of both worlds, combining steady income with the potential for superb capital gains.